Skip to ContentSkip to Navigation
About us Latest news News News articles

Risk factors for late graft failure and mortality in renal transplantation

09 February 2011

PhD ceremony: Mr. A.P.J. Vries, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Risk factors for late graft failure and mortality in renal transplantation

Promotor(s): prof. R.O.B. Gans, prof. W.J. van Son

Faculty: Medical Sciences

 

Despite all improvements in transplant medicine, renal transplant patients have a high risk for cardiovascular mortality. A measure of heart failure, impaired renal allograft function, and antihypertensive medication, explained the excess risk for cardiovascular mortality to a greater extent than the presence of the metabolic syndrome.

A year after the transplantation, a majority of renal transplant recipients had developed the metabolic syndrome which is a risk factor for cardiovascular disease. The metabolic syndrome was defined as a complex of overweight or obesity, high blood pressure and an unfavourable profile of cholesterol variables. The metabolic syndrome is associated with impaired renal allograft function and increased insulin resistance.

Women suffered more often from post-transplant weight gain and metabolic syndrome than men. Overweight, in particular central obesity, and the immunosuppressant prednisolon were found as most important determinants of insulin resistance. Renal transplant recipients had a 6 to 7 times higher risk of premature mortality as compared to matched controls in the general population. A measure of heart failure, impaired renal allograft function, and antihypertensive medication, explained the cardiovascular risk factors more than the presence of the metabolic syndrome.

 

Last modified:13 March 2020 01.11 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.